PETER MUELLER Insider Trading
Get free email notifications about insider trading for PETER MUELLER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER MUELLER. PETER MUELLER is a CSO & EVP Drug Innovation in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a CSO & SVP Drug Discovery in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a CSO&EVP Drug Innov&Realization in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a EVP Drug Disc., Innov & Realiz in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a EVP Drug Innov.& Realiz, CSO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a EVP Global R&D, CSO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a EVP, Global R&D, CSO in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a Director in BioXcel Therapeutics, Inc. ($BTAI).
Address: C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE 02139 MA
Companies in which PETER MUELLER is an Insider
BioXcel Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER MUELLER: Director
Holdings: 168,320 shares
Latest Transaction: May 26 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VERTEX PHARMACEUTICALS INC / MA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER MUELLER: EVP Global R&D, CSO, EVP, Global R&D, CSO, EVP Drug Innov.& Realiz, CSO, CSO&EVP Drug Innov&Realization, CSO & EVP Drug Innovation, EVP Drug Disc., Innov & Realiz, CSO & SVP Drug Discovery
Holdings: 133,735 shares
Current Value: $11,613,547
Latest Transaction: Feb 07 2011
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PETER MUELLER
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 26 2020 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 49.74 | 5,000 | 248,700 | 5,000 | |
| May 26 2020 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 49.74 | 20,000 | 994,800 | 20,000 | |
| Aug 26 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 9.34 | 1,554 | 14,514 | 168,320 | 166.8 K to 168.3 K (+0.93 %) |
| Aug 23 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 8.83 | 6,646 | 58,684 | 166,766 | 160.1 K to 166.8 K (+4.15 %) |
| Aug 23 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 8.42 | 1,800 | 15,156 | 160,120 | 158.3 K to 160.1 K (+1.14 %) |
| May 28 2019 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Option Exercise | A | 10.04 | 14,700 | 147,588 | 14,700 | |
| Dec 07 2018 | BTAI | BioXcel Therapeuti ... | MUELLER PETER | Director | Buy | P | 5.01 | 6,905 | 34,594 | 158,320 | 151.4 K to 158.3 K (+4.56 %) |